PMVP
Pmv Pharmaceuticals Inc
Precision oncology company developing p53-targeted therapies
CUSIP: 69353Y103HealthcareUS1 holder
Total Value
$41.36M
Total Shares
1.79M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$41.36M1.79M sharesUnchanged